IL18 and metabolic dysfunction-associated steatotic liver disease: Increasing evidence suggests that circulating markers of the systemic inflammatory response, including hs-CRP, TNF-a, IL-1, IL-6, and IL-18, are increased in patients with NAFLD and experimental models (21, 22).